XYLENTRA Trademark

Trademark Overview

On Monday, August 18, 2014, a trademark application was filed for XYLENTRA with the United States Patent and Trademark Office. The USPTO has given the XYLENTRA trademark a serial number of 86369012. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, November 19, 2020. This trademark is owned by Issar Pharmaceuticals. The XYLENTRA trademark is filed in the Pharmaceutical Products category with the following description:

Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Benzol detoxification agents for medical purposes; Cleansing solutions for medical use; Clinical medical reagents; Medical and surgical dressings; Medical cleansers for skin and wounds; Medical dressings
xylentra

General Information

Serial Number86369012
Word MarkXYLENTRA
Filing DateMonday, August 18, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, November 19, 2020
Registration Number4801030
Registration DateTuesday, August 25, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 27, 2015

Trademark Statements

Goods and ServicesAmino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Benzol detoxification agents for medical purposes; Cleansing solutions for medical use; Clinical medical reagents; Medical and surgical dressings; Medical cleansers for skin and wounds; Medical dressings

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 27, 2014
Primary Code005
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateFriday, May 1, 2015

Trademark Owner History

Party NameIssar Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWashington, DC 20036
Party NameIssar Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20036
Party NameIssar Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20036

Trademark Events

Event DateEvent Description
Monday, December 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 21, 2014NEW APPLICATION ENTERED
Wednesday, August 27, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 1, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, December 1, 2014ASSIGNED TO EXAMINER
Wednesday, January 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2014NON-FINAL ACTION WRITTEN
Tuesday, December 2, 2014NON-FINAL ACTION E-MAILED
Tuesday, December 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 4, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 11, 2014ASSIGNED TO LIE
Thursday, December 18, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 18, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 20, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 15, 2015USE AMENDMENT FILED
Tuesday, July 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 17, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 25, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, September 5, 2020TEAS SECTION 8 RECEIVED
Tuesday, January 27, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 15, 2015TEAS STATEMENT OF USE RECEIVED
Monday, July 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 19, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 19, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, November 19, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sunday, August 25, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

xylentra medical purposes dressings amino reagents surgical clinical cleansers wounds skin